Related Experiment Video
Updated: Jan 23, 2026

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging
Published on: March 17, 2023
Development of Theragnostic Tool Using NIR Fluorescence Probe Targeting Mitochondria in Glioma Cells
Yeonjeong Chu1,2, Min Chul Shin1, June Sung1
1Department of Molecular Science and Technology , Ajou University , Suwon 16499 , Republic of Korea.
Abstract:
Because mitochondria are essential organelles for regulating energy homeostasis and intrinsic apoptosis, the perturbation of mitochondrial functions has been considered as an anticancer treatment. In this study, a new near-infrared (NIR) fluorescent probe, SiR-Mito11 was developed as a theragnostic agent for brain tumor by targeting mitochondria. SiR-Mito11 exhibited potential anticancer activity against glioma cells but tolerance in normal neuronal cells. We further confirmed that the selective accumulation of SiR-Mito11 in glioma cells disrupted mitochondria membrane potential, followed by apoptotic cell death.
Insights
A novel near-infrared fluorescent probe, SiR-Mito11, selectively targets brain tumor cells, disrupting mitochondria and inducing cancer cell death while sparing normal neurons.
Area of Science:
- Mitochondrial biology
- Cancer therapy
- Biomedical imaging
Background:
- Mitochondria are crucial for cellular energy and apoptosis.
- Mitochondrial dysfunction is a target for anticancer strategies.
- Targeting brain tumors requires agents with high specificity.
Purpose of the Study:
- To develop a theragnostic agent for brain tumors.
- To investigate a new near-infrared fluorescent probe, SiR-Mito11.
- To evaluate the selective anticancer activity of SiR-Mito11.
Main Methods:
- Synthesis and characterization of SiR-Mito11.
- In vitro evaluation of SiR-Mito11 on glioma and normal neuronal cells.
- Assessment of mitochondrial membrane potential disruption and apoptosis induction.
Main Results:
- SiR-Mito11 demonstrated selective accumulation in glioma cells.
- The probe exhibited anticancer activity against glioma cells.
- Normal neuronal cells showed tolerance to SiR-Mito11.
- SiR-Mito11 disrupted mitochondrial membrane potential, leading to apoptosis.
Conclusions:
- SiR-Mito11 is a promising theragnostic agent for brain tumors.
- Selective mitochondrial targeting offers a potential therapeutic strategy.
- SiR-Mito11 warrants further investigation for clinical application.
More Related Videos
11:49Isolation of Conditionally Immortalized Mouse Glomerular Endothelial Cells with Fluorescent Mitochondria
Published on: September 13, 2022
14:10Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Related Concept Videos
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Mitochondria
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Zygotic Development And Stem Cell Formation
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...